Last week, Xconomy’s Luke Zimmerman posted a great article entitled LinkedIn: The Quiet Force Transforming Biotech & Pharma.   It examined how professionals in our space are using the online network to form strategic relationships, recruit top talent and even generate sales leads.  I can personally attest to the power of LinkedIn as it continually drives a steady stream of targeted traffic to the Clinipace web site.

With the release of Clinipace’s latest whitepaper – Trends and Considerations on Global Cardiovascular Drug Development (free download) – I wanted to share several of LinkedIn’s leading cardiovascular drug development and medical device groups.  See below for details – links take you to group web pages without being logged into LinkedIn.  Please feel free to add any groups I have missed in the comments section.

  • American College Of Cardiology (Very Active: 4,474 members)  ACC’s LinkedIn group features the latest news from the College, including more information about ACC’s initiatives in education, science and quality, advocacy and member services.The ACC is a thriving, international organization with 40,000 cardiovascular specialist members. Our mission is to advocate for quality cardiovascular care—through education, research promotion, development and application of standards and guidelines—and to influence health care policy.
  • Cardiovascular Medical Devices Group (Very Active: 14,982 members)  The Cardiovascular Medical Devices Group is intended to network all those around the world involved in the development and application of Cardiovascular Medical Devices. Product groups include Pacemakers, ICDs, CRT, EP diagnostics and ablation, vascular intervention (PTCA, stents etc.), echo, ECG etc.
  • Medical Device Engineers Cardiovascular, Orthopedic, Imaging,… (Very Active: · 1,579 members)  A subgroup of Medical Device Field – MDField Group.  This group is for medical professionals who appreciate the value of networking and want to take advantage of social media technologies to expand their relations and share their expertise. It combines all medical professionals to allow them to interact with one another and develop long-term relationships.

To download a free copy of “Trends and Considerations on Global Cardiovascular Drug Development,” visit